Skip to main content
Fig. 3 | BMC Chemistry

Fig. 3

From: Rhodanine-3-acetamide derivatives as aldose and aldehyde reductase inhibitors to treat diabetic complications: synthesis, biological evaluation, molecular docking and simulation studies

Fig. 3

The overlap of all the docked inhibitors 3(a–g) inside the active site of aldehyde reductase (ALR1) (a) having FX4401 (black), 3a (green), 3b (pink), 3c (orange), 3d (blue), 3e (indigo), 3f (red) and 3g (light purple) in the presence of NAP350 (beige) and aldose reductase (ALR2) (b) having IDD594 (black), 3a (blue), 3b (light blue), 3c (light green), 3d (brown), 3e (grey), 3f (red) and 3g (light purple) in the presence of NADP + (beige) with aromatic surface representation

Back to article page

BMC Chemistry

ISSN: 2661-801X

Contact us